0      0

Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis

‐ Oct 4, 2020 11:36am

Credits: None available.



Credits: None available.

You must be logged in and own this session in order to post comments.